Universidade Federal de São Paulo, Disciplina de Gastroenterologia, São Paulo, SP, Brazil.
Universidade Federal de São Paulo, Escola Paulista de Enfermagem, São Paulo, SP, Brazil.
Braz J Infect Dis. 2021 Mar-Apr;25(2):101546. doi: 10.1016/j.bjid.2021.101546. Epub 2021 Feb 23.
Hepatitis C virus (HCV) infection continues to be an important public health problem worldwide. Despite the availability of drugs that promote the cure of infection in more than 95% of cases, the identification of HCV carriers remains a major challenge.
To evaluate a strategy for identifying HCV carriers based on combined criteria: screening in emergency units and specialty outpatient clinics of a tertiary hospital and among older adults (≥45 years), both suggested as efficient in epidemiological studies.
A cross-sectional, analytical and descriptive study was conducted on individuals of both sexes, aged 45 years and older, attending the emergency department and specialty outpatient clinics of a University Hospital in São Paulo, Brazil, from January 2016 to June 2018. After giving formal consent, the patients were submitted to a standardized interview and rapid testing for the identification of HCV antibodies (SD BIOLINE® anti-HCV).
A total of 606 adult patients (62% women and 37% men) were evaluated. The mean age was 62±10 years. Four positive tests were identified, with confirmation by conventional serology and HCV-RNA determination. Thus, the prevalence of HCV identified in the sample was 0.66%. All patients had a history of risk factors for infection.
The strategies of birth-cohort testing and screening in emergency medical services for the identification of HCV carries, both suggested in the literature as efficient for the diagnosis of hepatitis C, resulted in a low rate of HCV infection. These findings highlight the magnitude of the challenge of identifying asymptomatic HCV carriers in Brazil.
丙型肝炎病毒(HCV)感染仍然是全球一个重要的公共卫生问题。尽管有可促进 95%以上病例治愈感染的药物,但HCV 携带者的识别仍然是一个主要挑战。
评估一种基于联合标准的 HCV 携带者识别策略:在一家三级医院的急诊部和专科门诊以及老年人群(≥45 岁)中进行筛查,这两种方法在流行病学研究中均被认为是有效的。
对 2016 年 1 月至 2018 年 6 月期间在巴西圣保罗一所大学医院急诊部和专科门诊就诊的 45 岁及以上的男女患者进行了一项横断面、分析性和描述性研究。在获得正式同意后,患者接受了标准化的访谈和快速 HCV 抗体检测(SD BIOLINE®抗-HCV)。
共评估了 606 名成年患者(62%为女性,37%为男性)。平均年龄为 62±10 岁。发现了 4 例阳性检测,通过常规血清学和 HCV-RNA 确定进行了确认。因此,在样本中确定的 HCV 患病率为 0.66%。所有患者均有感染危险因素的病史。
文献中建议的基于出生队列的检测和在急诊医疗服务中进行筛查以识别 HCV 携带者的策略,都被认为是诊断丙型肝炎的有效方法,但这些策略导致 HCV 感染率较低。这些发现突显了在巴西识别无症状 HCV 携带者的挑战程度。